Apoptosis 2006, 11:57–66.CrossRef 2. Bagalkot V, Farokhzad OC, Langer R, Jon S: An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl 2006, 45:8149–8152.CrossRef 3. Taghdisi SM, Abnous K, Mosaffa F, Behravan J: Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer. J Drug Target 2010, 18:277–281.CrossRef 4. Jain R, Dandekar P, Loretz B, Melero A, Stauner T, Wenz G, Koch M, Lehr CM: Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol. Int J Pharm 2011, 240:147–155.CrossRef 5. Georgelin T, Bombard S, Siaugue JM, Cabuil V: Nanoparticle-mediated
delivery of bleomycin. Angew Chem Int Ed Engl 2010, 49:8897–8901.CrossRef 6. Cheung RY, Ying Y, Rauth AM, Marcon N, Yu Wu X: Biodegradable dextran-based microspheres for delivery of anticancer drug MLN2238 mitomycin C. Biomaterials 2005, 26:5375–5385.CrossRef 7. Lian HY, Hu M, Liu CH, Yamauchi Y, Wu KC: Highly biocompatible, hollow coordination polymer nanoparticles
as cisplatin carriers for efficient intracellular drug delivery. Chem Commun (Camb) 2012, 48:5151–5153.CrossRef 8. Fishbein I, Brauner R, Chorny M, Gao J, Chen X, Laks H, Golomb G: Local delivery of mithramycin restores BI 2536 manufacturer vascular reactivity and inhibits neointimal formation in injured arteries and vascular grafts. J Control Release 2001, 77:167–181.CrossRef 9. Zhong Z, Wan Y, Shi S, Han EX 527 solubility dmso J, Zhang Z, Sun X: Co-delivery of adenovirus and carmustine by anionic liposomes with synergistic anti-tumor effects. Pharm Res 2012, 29:145–157.CrossRef
10. Dorozhkin SV: Calcium orthophosphates as bioceramics: state of the art. J Funct Biomater 2010, 1:22–107.CrossRef 11. Shi Z, Huang X, Cai Y, Tang R, Yang D: Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells. Acta biomater 2009, 5:338–345.CrossRef 12. Qing F, Wang Z, Hong Y, Liu M, Guo B, Luo H, Zhang X: Selective effects of hydroxyapatite nanoparticles on osteosarcoma cells and osteoblasts. J Mater Sci Mater Med 2012, 23:2245–2251.CrossRef 13. Liu X, Zhao M, Lu J, Ma J, Wei J, Wei Interleukin-2 receptor S: Cell responses to two kinds of nanohydroxyapatite with different sizes and crystallinities. Int J Nanomedicine 2012, 7:1239–1250.CrossRef 14. Xu Z, Liu C, Wei J, Sun J: Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts. J Appl Toxicol 2012, 32:429–435.CrossRef 15. Wang L, Zhou G, Liu H, Niu X, Han J, Zheng L, Fan Y: Nano-hydroxyapatite particles induce apoptosis on MC3T3-E1 cells and tissue cells in SD rats. Nanoscale 2012, 4:2894–2899.CrossRef 16. Ea HK, Monceau V, Camors E, Cohen-Solal M, Charlemagne D, Lioté F: Annexin 5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystals.